These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1084623)

  • 1. [Kinetics of populations of theta+ and theta- cells in the lymph nodes of KR/j mice during methylcholanthrene carcinogenesis].
    Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Vopr Onkol; 1976; 22(3):54-60. PubMed ID: 1084623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concentration of theta-plus-lymphocytes in the regional and distant lymph nodes C3H/Sn strain mice during development of primary methylcholanthrene sarcomas].
    Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Biull Eksp Biol Med; 1975 Jan; 79(1):57-9. PubMed ID: 1078631
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autoradiographic study of DNA metabolism in different populations of lymphocytes during chemical carcinogenesis is mice of the BALB/c strain].
    Umanskiĭ IuA; Gudim-Devkovich KA
    Tsitologiia; 1977 Sep; 19(9):1000-5. PubMed ID: 303824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells.
    Osugi M
    Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of blocking antibodies in immunological enhancement.
    Takasugi M; Klein E
    Immunology; 1971 Oct; 21(4):675-84. PubMed ID: 5121758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

  • 10. [Structuro-functional changes in lymphoid populations during the course of carcinogenesis].
    Stepanova EN; Aĭrapet'ian GP; Maĭskiĭ IN
    Biull Eksp Biol Med; 1980 May; 89(5):586-8. PubMed ID: 6772255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effect of isologous regional lymphnode cells from the methylcholanthrene-induced sarcoma bearing mice on the tumor in vivo.
    Kashihara E
    Acta Med Okayama (1952); 1970 Apr; 24(2):161-73. PubMed ID: 4247892
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of different T cells sets in the rejection of syngeneic chemically induced tumors.
    Shimizu K; Shen FW
    J Immunol; 1979 Mar; 122(3):1162-5. PubMed ID: 312820
    [No Abstract]   [Full Text] [Related]  

  • 15. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ; Focan C; Boniver J; Betz EH
    Pathol Eur; 1975; 10(4):317-25. PubMed ID: 1208123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of T and B-lymphocytes in macrophage migration inhibition in mice with methylcholanthrene-induced sarcoma].
    Galussio JC; Fridman JL; Tessler J
    Medicina (B Aires); 1977; 37(3):264-70. PubMed ID: 302386
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 18. Non T suppressor cells in the lymph nodes of mice bearing methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1981; 27(3):217-22. PubMed ID: 6455309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of methylcholanthrene-induced tumors tested by draining lymph node assay in syngeneic rats.
    Ryzewska AG; Rybicka M; Kania A; Dabrowski M
    Neoplasma; 1980; 27(5):533-42. PubMed ID: 7231610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.